🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, asserting the corporations hid safety concerns that the drug posed to children's neurological development.

The lawsuit arrives thirty days after Donald Trump publicized an unproven link between using acetaminophen - alternatively called acetaminophen - while pregnant and autism in young ones.

The attorney general is suing the pharmaceutical giant, which previously sold the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he claimed they "betrayed America by profiting off of discomfort and marketing drugs regardless of the potential hazards."

The company states there is insufficient reliable data tying Tylenol to autism.

"These corporations deceived for years, intentionally threatening countless individuals to boost earnings," the attorney general, a Republican, declared.

Kenvue commented that it was "very worried by the perpetuation of misinformation on the safety of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its official site, the company also mentioned it had "regularly reviewed the applicable studies and there is lacking reliable evidence that indicates a verified association between taking acetaminophen and autism spectrum disorder."

Organizations acting on behalf of medical professionals and health professionals share this view.

ACOG has stated acetaminophen - the main ingredient in Tylenol - is among limited choices for expectant mothers to address pain and fever, which can pose major wellness concerns if left untreated.

"In over twenty years of studies on the use of acetaminophen in gestation, not a single reputable study has definitively established that the usage of paracetamol in any stage of pregnancy leads to neurological conditions in offspring," the organization commented.

The court filing cites latest statements from the Trump administration in arguing the drug is allegedly unsafe.

Recently, Trump raised alarms from medical authorities when he instructed women during pregnancy to "fight like hell" not to consume Tylenol when unwell.

The US Food and Drug Administration then published an announcement that physicians should think about restricting the usage of Tylenol, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head Kennedy, who supervises the FDA, had promised in spring to initiate "extensive scientific investigation" that would determine the origin of autism in a matter of months.

But specialists advised that discovering a sole reason of autism - thought by researchers to be the consequence of a complicated interplay of inherited and external influences - would prove challenging.

Autism is a category of permanent neurological difference and disability that impacts how persons encounter and relate to the surroundings, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - aligned with the former president who is running for the Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the science" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the firms "eliminate any promotional materials" that claims acetaminophen is secure for women during pregnancy.

The Texas lawsuit parallels the complaints of a group of mothers and fathers of minors with autism and ADHD who sued the manufacturers of Tylenol in two years ago.

A federal judge dismissed the case, stating research from the plaintiffs' authorities was lacking definitive proof.